Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037).
Ashley Zyhowski, Ken Ho, Craig W Hendrix, Douglas J Hartman, Barbara A Friedland, Natalia Teleshova, Peter L Anderson, Sharon L Hillier, Rhonda Brand, Stacey Edick, Amer Al-Khouja, Craig Hoesley, Jose A Fernández-Romero, Clifton W Kelly, Yuqing Jiao, Ratiya Pamela Kunjara Na Ayudhya, Nipun B Reddy, Jeanna Piper, Jose A Bauermeister, Claudia Melo, Nadjet Cornejal, Patrick Barnable, Devika Singh, Rachel Scheckter, Tara McClure
Journal of acquired immune deficiency syndromes (1999) 2025;97(4):379-386